MIMEDX Group, Inc.

Home
United States
Atlanta, GA
MIMEDX Group, Inc.

Patients are why we are here. MIMEDX has supplied over two million allografts, through both direct and consignment shipments.

MIMEDX is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a prom

ising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. For additional information, please visit www.mimedx.com.

07/27/2026

AMNIOEFFECT® is a tri-layer placental allograft used in surgical wound management that offers confident handling across a range of procedural applications.¹ Its thicker configuration may be particularly useful in protecting deeper surgical wounds that require additional coverage and handling characteristics.

AMNIOEFFECT has been used as an onlay allograft to cover and protect exposed tissues in a variety of surgical wounds, including:
•Debridement
•Amputations
•Complex incision management
•Tendon & ligament repair

Explore where AMNIOEFFECT fits in your surgical toolkit: https://bit.ly/AMNIOEFFECT

1. MIMEDX Internal Report, MM-RD-00116.

07/23/2026

Wound care centers are adapting to the 2026 Medicare reimbursement framework for skin substitute products.

Medicare now reimburses most skin substitute products at a national average of approximately $127.14 per cm² based on the amount applied only.

At MIMEDX, we are committed to helping wound care centers navigate the evolving reimbursement landscape with clarity and confidence.

Our portfolio includes a wide range of graft sizes to help match product coverage to wound dimensions and reduce waste.

Explore the portfolio: https://mimedx.info/PRODUCTS

07/22/2026

Upcoming live webinar! Join MIMEDX and Wound Care Today USA for Healing Complex Wounds with Autologous PRP: Clinical Evidence and Case-Based Outcomes with RegenKit®-Wound Gel.

This session will feature Peter Moyer, DPM, FACFAS, and Dorothy Kurtz Phelan, DPM, CWSP, D-FBAS, FACFAS, for a discussion on clinical evidence, case-based outcomes, and the role of autologous PRP wound gel in complex wound care.

Tuesday, August 11
12 PM ET | 11 AM CT | 9 AM PT

Register today: https://mimedx.info/RegenKit-Wound-Gel-WCT-USA-Webinar

07/21/2026

After 15+ years of trusted performance in surgery, AMNIOFIX® expands its impact.

AMNIOFIX Thyroid Shields provide an easy-to-apply protective barrier on the recurrent laryngeal nerve and parathyroid glands—thereby supporting the healing process. The product is composed of dehydrated human amnion/chorion membrane allografts and provides OR-efficient preconfigured sizing.

Backed by peer-reviewed clinical studies¹⁻³. Learn more: https://mimedx.info/Thyroid-Surgery

1. Clayman G, et al. J Interdiscip Histopathol. 2022;10(5):1-4. 2. Clayman GL, et al. Cell Transplant. 2022;31:9636897211073136. 3. Carling T. Endocrine. 2021;74(1):197-199.

07/20/2026

In chronic wound applications, PRP composition may be one of the most important considerations.

RegenKit®-Wound Gel supports point-of-care preparation of autologous PRP with a focus on delivering key biological components while reducing elements that may contribute to a disrupted wound environment — high platelet recovery, a 99% reduction in red blood cells, and a controlled cellular profile.

Interested in a demo? https://mimedx.info/RegenKit-Wound-Gel

07/16/2026

AMNIOFIX® is an advanced human amnion/chorion placental allograft that provides a protective barrier on wounds and thereby supports the development of granulation tissue and the healing process. It is available in sheet and fenestrated sheet configurations in a variety of sizes for surgical wounds.

Learn how AMNIOFIX can benefit your surgical practice at https://bit.ly/3vY9og9

07/15/2026

Phyllis' wound care team was direct with her: amputation was a real risk.

What happened instead was something her physician described as a crystallizing moment — not just closing a wound, but altering the course of a patient's life.

Watch her story: https://mimedx.info/Phyllis-Patient-Story

07/14/2026

G4Derm® Plus is a biomimetic matrix designed to optimally manage complex wounds.

G4Derm Plus utilizes self-assembling peptide technology to form a supportive scaffold that mimics the native Extracellular Matrix (ECM).¹⁻²

The resorbable biomimetic matrix facilitates:²⁻³
•Revascularization
•Granulation tissue formation
•Re-epithelization

Learn more: https://mimedx.info/G4Derm-Plus

G4Derm Plus is owned and manufactured by Gel4Med Inc.

1. Date on File, FDA 510(k) submission package. Gel4Med, Inc.
2. Data on File, Scanning Electron Microscopy of G4Derm Plus. Gel4Med Inc.
3. Data on File, G4Derm Plus Full-Thickness Excisional Wound Healing Study in Swine. Gel4Med, Inc.
4. Tsuji T, et al. J Microsc. 1979;115(2):165‑173.

07/13/2026

The 4-week mark is a critical decision point in wound care.

When wounds fail to show meaningful reduction, it may be time to reassess your approach.

You have the power to act. Consider stepping up with MIMEDX placental allografts and RegenKit®-Wound Gel.

Learn more: https://mimedx.info/Wound-Clinicians

07/09/2026

What happens inside a wound scaffold product after implantation? The answer depends on which product you choose.

HELIOGEN® Fibrillar Collagen Matrix and MariGen Micro® (Kerecis) were subcutaneously implanted in an animal model to evaluate the host response to the scaffolds at 1 and 4 weeks.

The histopathology results may surprise you. View the full video presentation to see what happened at the cellular level: https://mimedx.info/HELIOGEN

HELIOGEN and MIMEDX are trademarks of MIMEDX Group, Inc. All other trademarks are owned by their respective owners.

Address

Atlanta, GA

Telephone

+17706519100

Website

http://www.mimedx.com/

Alerts

Be the first to know and let us send you an email when MIMEDX Group, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Atlanta?